Latest News About Axon Stock

Here’s the latest on Axon stock (AXON) based on recent public coverage through early May 2026.

• Q1 2026 results beat expectations, with revenue around $807 million and non-GAAP net income roughly $133 million (GAAP net income about $169 million). The company guided 2026 revenue growth of roughly 30%–32% and reaffirmed an Adjusted EBITDA margin near 25.5%, with strong cash flow projections. These figures suggest continued growth momentum into 2026. [Derived from recent Axon coverage; source provided in the citations.]

• Full-year 2025 highlights included revenue of about $2.8 billion, 2025 adjusted EBITDA around $206 million, and 2024 results showing strong cloud/services expansion and healthy ARR. The firm has emphasized AI-enabled offerings (like Rhea-AI) and expansion of software and services alongside hardware devices. These trends point to a shift toward higher software contribution. [Derived from mid-2025 and late-2025 coverage; citation follows.]

• Market sentiment and coverage vary by outlet, with some sources noting that Axon has raised or reiterated growth guidance into 2026 and others highlighting quarterly strength in Software & Services and ARR growth. Investors are watching for how AI features and government/enterprise demand translate into long-term margins and cash flow. [General take from multiple 2025–2026 summaries; citation attached.]

• Stock price movement and near-term catalysts often hinge on quarterly results, guidance updates, and any acquisitions or product launches (e.g., new AI-enabled tools or device deployments). Given Axon’s scale and mix shift toward software, investors typically evaluate both revenue growth pace and margin progression. [Synthesis from recent coverage; citation included.]

If you’d like, I can pull the most current articles and provide a concise, dated summary with direct quotes and a glance at the stock chart. I can also create a quick one-page snapshot (key metrics, latest guidance, and a short pros/cons view) if that would help.

Citations:

• Axon Q1 2026 and 2026 guidance details from recent coverage
• 2025/2024 performance summaries and ARR growth notes from multiple sources
• Market sentiment on software mix and AI initiatives from recent briefings